---
category: news
title: "Castle Biosciences Publishes DecisionDx®-Melanoma Study on the Validation of the i31-GEP SLNB Artificial Intelligence Algorithm"
excerpt: "Castle Biosciences, Inc. (Nasdaq: CSTL), a company applying innovative diagnostics to inform disease management and improve patient outcomes, today announced the publication of a study validating performance of a novel algorithm designed to integrate the DecisionDx ® -Melanoma gene expression profile (GEP) test with clinicopathologic features (i31-GEP SLNB) to determine sentinel lymph node biopsy (SLNB) positivity risk in patients with cutaneous melanoma."
publishedDateTime: 2021-11-05T21:01:00Z
originalUrl: "https://apnews.com/press-release/business-wire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
webUrl: "https://apnews.com/press-release/business-wire/coronavirus-pandemic-science-technology-business-melanoma-b54532c71d214233b100c84c9001449d"
type: article
quality: 11
heat: 11
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

secured: "2LqV3oR1wdOjXjIYjRo0Lkf6AIfgAJkBy33y6WljTrWu/VGR3FYKeG4fRmfjfghOlD9T609LVoqF85cIUgmgAiK4o2Il06Ch3MxG1/d7Y/dS1SCo9/h7BGRnGGmfFfh3wlGXqoSUqIqyzvG3Lc9p1A2z1n5uvr2n/Q6jMjwTJlO9ul3l4o7rUexH+/3XReaYWZxbJuv4BlrnkwX71ICAqCrVqvIj4QImqgxj+xdeodzm7gPeNxSB9rJSFoV9GNy03rAL74yaXjZ47s7x/xil6Q+TepKbY/lYmAtJoZiQq554e5Mnt3rQTHQKMAj/ngZuwwjoeF9O1lPd8dZOAg9G5qDTakAeWkCpnyAKXA9kyY4=;P3URpVYjsYr6AQeszCFVPg=="
---

